Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Stockholders' Equity

v2.4.0.8
Consolidated Statement of Stockholders' Equity (USD $)
Total
Preferred Stock
Common Stock
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Balance at Dec. 31, 2013 $ (4,009,587) $ 8 $ 135,919 $ 313,111,788 $ (317,257,302)
Balance, shares at Dec. 31, 2013 135,919,423   135,919,423    
Balance, shares at Dec. 31, 2013   7,565      
Issued stock upon exercise of stock options, net (27,714)   189 (27,903)  
Issued stock upon exercise of stock options, net, shares     188,756    
Issued restricted stock 120   120    
Issued restricted stock, shares     120,000    
Conversion of Series B preferred stock to common stock, shares   (4,162)      
Conversion of Series B preferred stock to common stock, value   (5)      
Stock Issued During Period, Shares, Conversion of Convertible Securities     13,609,740    
Stock Issued During Period, Value, Conversion of Convertible Securities 0   13,610 (13,605)  
Issued warrants in connection with debt issuance 464,991     464,991  
Adjustments to Additional Paid in Capital, Recovery of Shareholder Profits 11,354     11,354  
Stock compensation expense 693,203     693,203  
Net loss (11,740,553)       (11,740,553)
Balance at Mar. 31, 2014 $ (14,608,186) $ 3 $ 149,838 $ 314,239,828 $ (328,997,855)
Balance, shares at Mar. 31, 2014 149,837,919   149,837,919    
Balance, shares at Mar. 31, 2014   3,403